DPP4 and cardiac hypertrophy: Recently a preclinical study has reported that diabetic mice treated with Dpp4 inhibitor exhibited modest cardiac hypertrophy, impairment of cardiac function, and dysregulated expression of genes and proteins controlling inflammation and cardiac fibrosis [75].